U.S. Approves Israeli App that Detects Skin Cancer

An Israeli company has created DermaCompare, an easy-to-use App that detects suspicious moles in the most efficient way, thus saving many lives.

Skin disease has been on the rise, including, for example, melanoma, acne, psoriasis and malasma, to name a few.

The US Food and Drug Administration (FDA) has approved the DermaCompare melanoma (skin cancer) diagnosis system developed by Israel’s Emerald Medical (formally DermaCare).

The affordable smartphone app, created with high-end Air Force Technology, enables tele-dermatology to detect possible melanomas and save lives.

Watch and see how easy and accessible it is!

Subscribe to Our FREE Newsletter for More Great Stories Like This One

United with Israel publishes stories like this every day. We believe that our work allows a more balanced view of Israel to emerge. With so much anti-Israel media bias out there from outlets like CNN and the BBC, helping the Holy Land means getting our message out to as many people as possible.

You can help.

Subscribe to our free newsletter to ensure that you get the latest and best stories from United with Israel. Together we can make a difference, and it starts with communication.

CLICK HERE TO SUBSCRIBE TO OUR FREE NEWSLETTER

Source: United with Israel